<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04339205</url>
  </required_header>
  <id_info>
    <org_study_id>Imaging study</org_study_id>
    <nct_id>NCT04339205</nct_id>
  </id_info>
  <brief_title>Diffusion Imaging in Acute Auto-immune Encephalitis</brief_title>
  <official_title>Diffusion Imaging in Acute Auto-immune Encephalitis : a Cohort of 80 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this non randomised retrospective study is to investigate the imaging (MRI) of
      auto-immune encephalitis at presentation, especially in diffusion-weighted sequences.

      Indeed, few series describe the MRI aspect of auto-immune at their beginning. Recognize early
      MRI abnormalities seen in auto-immune encephalitis could help reduce the time to positive
      diagnosis and improve the therapeutic management.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>MRI characterization, especially in Diffusion-weighted magnetic resonance imaging (DWI-MRI), of auto-immune encephalitis at presentation.</measure>
    <time_frame>at following-up until 24 months</time_frame>
    <description>The radiologist will analyze the MRI of patients with proved auto-immune encephalitis realized at presentation of the symptoms. If available, the following-up MRIs will also be analyzed.
At each assessment, four MRI sequences will be studied : diffusion, T2-weighted, susceptibility sensitive sequences, and T1 weighted after contrast enhanced with gadolinium.
The radiologist will analyse the signal abnormalities, their localisation and the trophicity of the brain.
We will then correlate the following clinical data collected for patients : age, sex, clinical presentation, clinical evolution, and tumor associated or not.</description>
  </primary_outcome>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Auto-immune Encephalitis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Analysis of every MRI at presentation of the symptoms and then over a period of 3 to 24 months if available.</intervention_name>
    <description>The radiologist will analyze the MRI of patients with proved auto-immune encephalitis realized at presentation of the symptoms. If available, the following-up MRIs will also be analyzed.
At each assessment, four MRI sequences will be studied : diffusion, T2-weighted, susceptibility sensitive sequences, and T1 weighted after contrast enhanced with gadolinium.
The radiologist will analyse the signal abnormalities, their localisation and the trophicity of the brain.
We will then correlate the following clinical data collected for patients : age, sex, clinical presentation, clinical evolution, and tumor associated or not.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with auto-immune encephalitis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Auto-immune encephalitis proved by biological results (blood and/or CSF sample)

        Exclusion Criteria:

          -  No MRI available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>François cotton, phd</last_name>
    <phone>04 78 56 91 00</phone>
    <email>francois.cotton@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Géraldine PICARD</last_name>
    <phone>04 72 35 58 42</phone>
    <email>geraldine.picard@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François COTTON, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Géraldine PICARD</last_name>
      <phone>04 72 35 58 42</phone>
      <email>geraldine.picard@chu-lyon.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 6, 2020</study_first_submitted>
  <study_first_submitted_qc>April 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 9, 2020</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Encephalitis</mesh_term>
    <mesh_term>Hashimoto Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

